Neurotez

Innovative Solutions for Brain Disorders

Print
Claim My Business
Form C
View on Netcapital
Security Type
Common Stock
Min Investment
$100
Location
Bridgewater, NJ
Offering Date
November 09, 2021
Expected Close Date
January 27, 2023
Target Raise
$10.00K-$500.00K
No. Investors
32
Security Price
$4
Valuation
$45,272,228
Website
neurotez.com
Number of Employees
7
Cash
$24,783
Revenue
$0
Short Term Debt
$0
Cost of Goods
$0
Long Term Debt
$62,255
Net Income
$-314,585

Company Description

We are Neurotez - a company passionately devoted to getting a meaningful treatment to cure or even prevent the onset and progression of Alzheimer’s disease.

Key Deal Facts

Currently there is an FDA approved drug on the market, but despite the limited evidence for its efficacy, it's available for $56,000 per patient per year - creating a $366 billion market in the US alone.
Drug as a biologic will get 12 years of market exclusivity from the US.
Data from pre-clinical studies demonstrating efficacy as a disease modification entity.

Management Team / Advisory Board Bios

Nikolaos Tezapsidis, PhD, President, CEO and Chairman of the Board
PhD in Biochemistry at the University of Sussex, UK
Founder of Neurotez Inc.
18+ years of biomedical research
Two awards from the Alzheimer's Association, USA
Awards from Welcome Trust and Science and Engineering Council, Uk, 50 publications

J. Wesson Ashford, Chief Medical Officer
MD and PhD in Neuroscience from UCLA
100+ publications on Alzheimer's disease
Senior Research Scientist at the Stanford/VA Aging Clinical Research Center and Alzheimer's Center

Jukka Karjalainen, Chief Operations Officer
25+ years of pharma experience in US, Canada, and Europe
Authored 55 original publications in top-rated international medical journals, Member of International Science Advisory Board
Amount Raised : $15,952
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment